Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis—a possible adjunct therapy

Simran Preet, Sanjay Bharati, Anshul Panjeta, Rupinder Tewari, Praveen Rishi

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

In view of the emergence of multidrug-resistant cancer cells, there is a need for therapeutic alternatives. Keeping this in mind, the present study was aimed at evaluating the synergism between nisin (an antimicrobial peptide) and doxorubicin (DOX) against DMBA-induced skin carcinogenesis. The possible tumoricidal activity of the combination was evaluated in terms of animal bioassay observations, changes in hisotological architecture of skin tissues, in situ apoptosis assay (TUNEL assay) and in terms of oxidant and antioxidant status of the skin tissues. In vivo additive effect of the combination was evidenced by larger decreases in mean tumour burden and tumour volume in mice treated with the combination than those treated with the drugs alone. Histological observations indicated that nisin-DOX therapy causes chromatin condensation and marginalisation of nuclear material in skin tissues of treated mice which correlated well with the results of TUNEL assay wherein a marked increase in the rate of apoptosis was revealed in tissues treated with the combination. A slightly increased oxidative stress in response to the adjunct therapy as compared to dox-alone-treated group was revealed by levels of lipid peroxidation (LPO) and nitrite generation in skin tissue-treated mice. An almost similar marginal enhancement in superoxide dismutase levels corresponding with a decrease in catalase activity could also be observed in nisin + DOX-treated groups as compared to nisin and dox-alone-treated groups. These results point towards the possible use of nisin as an adjunct to doxorubicin may help in developing alternate strategies to combat currently developing drug resistance in cancer cells.

Original languageEnglish
Pages (from-to)8301-8308
Number of pages8
JournalTumor Biology
Volume36
Issue number11
DOIs
Publication statusPublished - 01-11-2015

Fingerprint

Nisin
9,10-Dimethyl-1,2-benzanthracene
Doxorubicin
Skin
In Situ Nick-End Labeling
Tumor Burden
Apoptosis
Therapeutics
Nitrites
Drug Resistance
Oxidants
Biological Assay
Catalase
Lipid Peroxidation
Superoxide Dismutase
Chromatin
Neoplasms
Carcinogenesis
Oxidative Stress
Antioxidants

All Science Journal Classification (ASJC) codes

  • Cancer Research

Cite this

Preet, Simran ; Bharati, Sanjay ; Panjeta, Anshul ; Tewari, Rupinder ; Rishi, Praveen. / Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis—a possible adjunct therapy. In: Tumor Biology. 2015 ; Vol. 36, No. 11. pp. 8301-8308.
@article{a5aa8001c3014b54a710d0a282ee054f,
title = "Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis—a possible adjunct therapy",
abstract = "In view of the emergence of multidrug-resistant cancer cells, there is a need for therapeutic alternatives. Keeping this in mind, the present study was aimed at evaluating the synergism between nisin (an antimicrobial peptide) and doxorubicin (DOX) against DMBA-induced skin carcinogenesis. The possible tumoricidal activity of the combination was evaluated in terms of animal bioassay observations, changes in hisotological architecture of skin tissues, in situ apoptosis assay (TUNEL assay) and in terms of oxidant and antioxidant status of the skin tissues. In vivo additive effect of the combination was evidenced by larger decreases in mean tumour burden and tumour volume in mice treated with the combination than those treated with the drugs alone. Histological observations indicated that nisin-DOX therapy causes chromatin condensation and marginalisation of nuclear material in skin tissues of treated mice which correlated well with the results of TUNEL assay wherein a marked increase in the rate of apoptosis was revealed in tissues treated with the combination. A slightly increased oxidative stress in response to the adjunct therapy as compared to dox-alone-treated group was revealed by levels of lipid peroxidation (LPO) and nitrite generation in skin tissue-treated mice. An almost similar marginal enhancement in superoxide dismutase levels corresponding with a decrease in catalase activity could also be observed in nisin + DOX-treated groups as compared to nisin and dox-alone-treated groups. These results point towards the possible use of nisin as an adjunct to doxorubicin may help in developing alternate strategies to combat currently developing drug resistance in cancer cells.",
author = "Simran Preet and Sanjay Bharati and Anshul Panjeta and Rupinder Tewari and Praveen Rishi",
year = "2015",
month = "11",
day = "1",
doi = "10.1007/s13277-015-3571-3",
language = "English",
volume = "36",
pages = "8301--8308",
journal = "Tumor Biology",
issn = "1010-4283",
publisher = "Springer Netherlands",
number = "11",

}

Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis—a possible adjunct therapy. / Preet, Simran; Bharati, Sanjay; Panjeta, Anshul; Tewari, Rupinder; Rishi, Praveen.

In: Tumor Biology, Vol. 36, No. 11, 01.11.2015, p. 8301-8308.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of nisin and doxorubicin on DMBA-induced skin carcinogenesis—a possible adjunct therapy

AU - Preet, Simran

AU - Bharati, Sanjay

AU - Panjeta, Anshul

AU - Tewari, Rupinder

AU - Rishi, Praveen

PY - 2015/11/1

Y1 - 2015/11/1

N2 - In view of the emergence of multidrug-resistant cancer cells, there is a need for therapeutic alternatives. Keeping this in mind, the present study was aimed at evaluating the synergism between nisin (an antimicrobial peptide) and doxorubicin (DOX) against DMBA-induced skin carcinogenesis. The possible tumoricidal activity of the combination was evaluated in terms of animal bioassay observations, changes in hisotological architecture of skin tissues, in situ apoptosis assay (TUNEL assay) and in terms of oxidant and antioxidant status of the skin tissues. In vivo additive effect of the combination was evidenced by larger decreases in mean tumour burden and tumour volume in mice treated with the combination than those treated with the drugs alone. Histological observations indicated that nisin-DOX therapy causes chromatin condensation and marginalisation of nuclear material in skin tissues of treated mice which correlated well with the results of TUNEL assay wherein a marked increase in the rate of apoptosis was revealed in tissues treated with the combination. A slightly increased oxidative stress in response to the adjunct therapy as compared to dox-alone-treated group was revealed by levels of lipid peroxidation (LPO) and nitrite generation in skin tissue-treated mice. An almost similar marginal enhancement in superoxide dismutase levels corresponding with a decrease in catalase activity could also be observed in nisin + DOX-treated groups as compared to nisin and dox-alone-treated groups. These results point towards the possible use of nisin as an adjunct to doxorubicin may help in developing alternate strategies to combat currently developing drug resistance in cancer cells.

AB - In view of the emergence of multidrug-resistant cancer cells, there is a need for therapeutic alternatives. Keeping this in mind, the present study was aimed at evaluating the synergism between nisin (an antimicrobial peptide) and doxorubicin (DOX) against DMBA-induced skin carcinogenesis. The possible tumoricidal activity of the combination was evaluated in terms of animal bioassay observations, changes in hisotological architecture of skin tissues, in situ apoptosis assay (TUNEL assay) and in terms of oxidant and antioxidant status of the skin tissues. In vivo additive effect of the combination was evidenced by larger decreases in mean tumour burden and tumour volume in mice treated with the combination than those treated with the drugs alone. Histological observations indicated that nisin-DOX therapy causes chromatin condensation and marginalisation of nuclear material in skin tissues of treated mice which correlated well with the results of TUNEL assay wherein a marked increase in the rate of apoptosis was revealed in tissues treated with the combination. A slightly increased oxidative stress in response to the adjunct therapy as compared to dox-alone-treated group was revealed by levels of lipid peroxidation (LPO) and nitrite generation in skin tissue-treated mice. An almost similar marginal enhancement in superoxide dismutase levels corresponding with a decrease in catalase activity could also be observed in nisin + DOX-treated groups as compared to nisin and dox-alone-treated groups. These results point towards the possible use of nisin as an adjunct to doxorubicin may help in developing alternate strategies to combat currently developing drug resistance in cancer cells.

UR - http://www.scopus.com/inward/record.url?scp=84949086515&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949086515&partnerID=8YFLogxK

U2 - 10.1007/s13277-015-3571-3

DO - 10.1007/s13277-015-3571-3

M3 - Article

C2 - 26002579

AN - SCOPUS:84949086515

VL - 36

SP - 8301

EP - 8308

JO - Tumor Biology

JF - Tumor Biology

SN - 1010-4283

IS - 11

ER -